Identification
NameStearic acid
Accession NumberDB03193  (EXPT02965)
TypeSmall Molecule
GroupsExperimental
Description

Stearic acid (IUPAC systematic name: octadecanoic acid) is one of the useful types of saturated fatty acids that comes from many animal and vegetable fats and oils. It is a waxy solid. [Wikipedia]

Structure
Thumb
Synonyms
1-Heptadecanecarboxylic acid
Cetylacetic acid
Fatty acids C16-18
Isooctadecanoic acid
Isostearic acid
N-octadecanoic acidd
Octadecanoic acid
Octadecansaeure
Octadecoic acid
OLA
Stearate
Stearinsaeure
External IDs Caswell No. 801D / FEMA No. 3035 / NSC-25956 / NSC-261168
Product Ingredients Not Available
Approved Prescription ProductsNot Available
Approved Generic Prescription ProductsNot Available
Approved Over the Counter ProductsNot Available
Unapproved/Other Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Cellbn First Care CleanserCream16 g/100mLTopicalWorldcostec.co.,ltd2017-05-26Not applicableUs
Dr. G Pore Deep Clearing FoamCream15 g/10mLTopicalGOWOONSESANG COSMETICS CO., LTD.2016-03-01Not applicableUs
Dr.g A-clear FoamCream20 g/100mLTopicalGOWOONSESANG COSMETICS CO., LTD.2015-07-05Not applicableUs
Dr.g Hyper Brightening Cleansing FoamCream8 g/100mLTopicalGOWOONSESANG COSMETICS CO., LTD.2015-07-05Not applicableUs
Dr.g Red-blemish Moisture Cleansing FoamCream25 g/100mLTopicalGOWOONSESANG COSMETICS CO., LTD.2015-07-05Not applicableUs
Jinhwagwangsu BubbleSoap120 mg/gTopicalC Pbio Co., Ltd2015-06-01Not applicableUs
Jinhwagwangsu HairSoap12 g/100gTopicalC Pbio Co., Ltd2016-01-25Not applicableUs
Obeo Baby BubbleSoap120 mg/gTopicalC Pbio Co., Ltd2015-05-29Not applicableUs
W Lab Black Kill Pore CleanerGel.4 g/20mLTopicalWow Ventures2016-02-01Not applicableUs
International Brands
NameCompany
Bonderlube 235Not Available
C-Lube 10Not Available
DermaroneNot Available
Emersol 153NFNot Available
Flexichem BNot Available
HystreneNot Available
IndustreneNot Available
LunacNot Available
Prifac 2918Not Available
ProdhygineNot Available
Brand mixtures
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
For SopeLiquidTopicalRougier Pharma Division Of Ratiopharm Inc1960-12-311999-09-27Canada
Isa Knox Ageless Serum Makeup Base 10CreamTopicalLg Household & Health Care Ltd.2010-07-04Not applicableUs
Isaknox Ageless Serum Moist Pearl BaseLiquidTopicalLg Household & Health Care Ltd.2010-08-31Not applicableUs
Medi Hydro Dp Bb CreamCreamTopicalMbg Inc (Korea Institute of Science Development)2016-08-082017-08-08Us
Sha-lemOintmentTopicalShalem Products, Inc.1992-05-08Not applicableUs
Sooryehan Onbit Essence Foundation 21CreamTopicalLg Household & Health Care Ltd.2011-08-25Not applicableUs
Categories
UNII4ELV7Z65AP
CAS number57-11-4
WeightAverage: 284.4772
Monoisotopic: 284.271530396
Chemical FormulaC18H36O2
InChI KeyQIQXTHQIDYTFRH-UHFFFAOYSA-N
InChI
InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20)
IUPAC Name
octadecanoic acid
SMILES
CCCCCCCCCCCCCCCCCC(O)=O
Pharmacology
IndicationNot Available
Structured Indications Not Available
PharmacodynamicsNot Available
Mechanism of action
TargetKindPharmacological actionActionsOrganismUniProt ID
Group IID secretory phospholipase A2ProteinunknownNot AvailableHumanQ9UNK4 details
Peroxisome proliferator-activated receptor alphaProteinunknownNot AvailableHumanQ07869 details
Related Articles
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
MetabolismNot Available
Route of eliminationNot Available
Half lifeNot Available
ClearanceNot Available
Toxicity

Acute oral toxicity (LD50): 4640 mg/kg [Rat]. Acute dermal toxicity (LD50): >5000 mg/kg [Rabbit].

Affected organisms
  • Humans and other mammals
Pathways
PathwayCategorySMPDB ID
Plasmalogen SynthesisMetabolicSMP00479
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty AcidsMetabolicSMP00482
Pharmacogenomic Effects/ADRs Not Available
Interactions
Drug Interactions Not Available
Food InteractionsNot Available
References
Synthesis Reference

Arnold W. Fogel, "12-hydroxy stearic acid esters, compositions based upon same and methods of using and making such compositions." U.S. Patent US5993861, issued July, 1998.

US5993861
General ReferencesNot Available
External Links
ATC CodesNot Available
AHFS CodesNot Available
PDB Entries
FDA labelNot Available
MSDSDownload (73.6 KB)
Clinical Trials
Clinical Trials Not Available
Pharmacoeconomics
ManufacturersNot Available
PackagersNot Available
Dosage forms
FormRouteStrength
CreamTopical16 g/100mL
CreamTopical15 g/10mL
CreamTopical20 g/100mL
CreamTopical8 g/100mL
CreamTopical25 g/100mL
CreamTopical
LiquidTopical
SoapTopical120 mg/g
SoapTopical12 g/100g
OintmentTopical
GelTopical.4 g/20mL
PricesNot Available
PatentsNot Available
Properties
StateSolid
Experimental Properties
PropertyValueSource
melting point (°C)68.8 °CPhysProp
boiling point (°C)383 °CPhysProp
water solubility0.597 mg/L (at 25 °C)YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP8.23SANGSTER (1993)
Predicted Properties
PropertyValueSource
Water Solubility6.61e-05 mg/mLALOGPS
logP8.02ALOGPS
logP7.15ChemAxon
logS-6.6ALOGPS
pKa (Strongest Acidic)4.95ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area37.3 Å2ChemAxon
Rotatable Bond Count16ChemAxon
Refractivity86.29 m3·mol-1ChemAxon
Polarizability38.64 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9888
Blood Brain Barrier+0.9488
Caco-2 permeable+0.8326
P-glycoprotein substrateNon-substrate0.6321
P-glycoprotein inhibitor INon-inhibitor0.9598
P-glycoprotein inhibitor IINon-inhibitor0.9277
Renal organic cation transporterNon-inhibitor0.9266
CYP450 2C9 substrateNon-substrate0.7886
CYP450 2D6 substrateNon-substrate0.8956
CYP450 3A4 substrateNon-substrate0.6982
CYP450 1A2 substrateInhibitor0.8326
CYP450 2C9 inhibitorNon-inhibitor0.8808
CYP450 2D6 inhibitorNon-inhibitor0.9554
CYP450 2C19 inhibitorNon-inhibitor0.9578
CYP450 3A4 inhibitorNon-inhibitor0.9484
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9647
Ames testNon AMES toxic0.9865
CarcinogenicityNon-carcinogens0.6452
BiodegradationReady biodegradable0.8795
Rat acute toxicity1.3275 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9322
hERG inhibition (predictor II)Non-inhibitor0.8868
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397 )
Spectra
Mass Spec (NIST)Not Available
Spectra
Spectrum TypeDescriptionSplash Key
GC-MSGC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (1 TMS)splash10-0159-1900000000-9cc966384906cd35537dView in MoNA
GC-MSGC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)splash10-0159-0900000000-b87a9955374d11966ba6View in MoNA
GC-MSGC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (1 TMS)splash10-0100-9700000000-979da356343fa0697993View in MoNA
GC-MSGC-MS Spectrum - GC-MS (1 TMS)splash10-0159-2901000000-16194c704b7abd193647View in MoNA
Predicted GC-MSPredicted GC-MS Spectrum - GC-MSNot Available
GC-MSGC-MS Spectrum - EI-Bsplash10-06yo-9110000000-6f345827577cdc861acaView in MoNA
GC-MSGC-MS Spectrum - EI-Bsplash10-075c-9220000000-207b53a511763954eb66View in MoNA
GC-MSGC-MS Spectrum - GC-EI-TOFsplash10-014i-1900000000-d34fc01a79cc27a32080View in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 10V, Negative (Annotated)splash10-001i-0090000000-1368043827a20e28c172View in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 25V, Negative (Annotated)splash10-001i-0090000000-5c3fa1d38cf3d0a38d74View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT , negativesplash10-00lr-0090000000-a702a9f469dbb513856aView in MoNA
LC-MS/MSLC-MS/MS Spectrum - , negativesplash10-001i-0090000000-9441e6362046ae198384View in MoNA
LC-MS/MSLC-MS/MS Spectrum - , negativesplash10-001i-0090000000-9441e6362046ae198384View in MoNA
LC-MS/MSLC-MS/MS Spectrum - , negativesplash10-001i-0090000000-fbf3f8e91badb0ec251dView in MoNA
LC-MS/MSLC-MS/MS Spectrum - , negativesplash10-001i-0090000000-fbf3f8e91badb0ec251dView in MoNA
LC-MS/MSLC-MS/MS Spectrum - , negativesplash10-001i-0090000000-55efcdc9c7bfd521ef5aView in MoNA
LC-MS/MSLC-MS/MS Spectrum - , negativesplash10-001i-0090000000-55efcdc9c7bfd521ef5aView in MoNA
LC-MS/MSLC-MS/MS Spectrum - ESI-TOF 10V, NegativeNot Available
LC-MS/MSLC-MS/MS Spectrum - ESI-TOF , NegativeNot Available
LC-MS/MSLC-MS/MS Spectrum - ESI-TOF 20V, NegativeNot Available
LC-MS/MSLC-MS/MS Spectrum - ESI-TOF 30V, NegativeNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-014r-0090000000-34a309d09cb2def46a19View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-00kr-4690000000-f68e827f7ebccd80d5bfView in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-052f-8920000000-2e865f09d760af582c07View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-014r-0090000000-34a309d09cb2def46a19View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-00kr-4690000000-f68e827f7ebccd80d5bfView in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-052f-8920000000-2e865f09d760af582c07View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-001i-0090000000-b3ce35f839a30b41c718View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-00m0-1090000000-bbb339a3dbe1b9ba0d54View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0a4l-9240000000-1b84b49819fa37fce1aeView in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-001i-0090000000-b3ce35f839a30b41c718View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-00m0-1090000000-bbb339a3dbe1b9ba0d54View in MoNA
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0a4l-9240000000-1b84b49819fa37fce1aeView in MoNA
MSMass Spectrum (Electron Ionization)splash10-0c03-9200000000-5dd52f837d56d80fa968View in MoNA
1D NMR1H NMR SpectrumNot Available
1D NMR1H NMR SpectrumNot Available
1D NMR13C NMR SpectrumNot Available
1D NMR1H NMR SpectrumNot Available
1D NMR13C NMR SpectrumNot Available
2D NMR[1H,13C] 2D NMR SpectrumNot Available
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassFatty acids and conjugates
Direct ParentLong-chain fatty acids
Alternative ParentsStraight chain fatty acids / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
SubstituentsLong-chain fatty acid / Straight chain fatty acid / Monocarboxylic acid or derivatives / Carboxylic acid / Carboxylic acid derivative / Organic oxygen compound / Organic oxide / Hydrocarbon derivative / Organooxygen compound / Carbonyl group
Molecular FrameworkAliphatic acyclic compounds
External Descriptorslong-chain fatty acid, saturated fatty acid, straight-chain saturated fatty acid (CHEBI:28842 ) / Straight chain fatty acids, Saturated fatty acids (C01530 ) / Straight chain fatty acids (LMFA01010018 )

Targets

Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Phospholipase a2 activity
Specific Function:
PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. L-alpha-1-palmitoyl-2-linoleoyl phosphatidylethanolamine is more efficiently hydrolyzed than the other phospholipids examined.
Gene Name:
PLA2G2D
Uniprot ID:
Q9UNK4
Uniprot Name:
Group IID secretory phospholipase A2
Molecular Weight:
16546.1 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Zinc ion binding
Specific Function:
Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fa...
Gene Name:
PPARA
Uniprot ID:
Q07869
Uniprot Name:
Peroxisome proliferator-activated receptor alpha
Molecular Weight:
52224.595 Da
References
  1. Murakami K, Ide T, Suzuki M, Mochizuki T, Kadowaki T: Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun. 1999 Jul 14;260(3):609-13. [PubMed:10403814 ]

Carriers

Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Oleic acid binding
Specific Function:
FABP are thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters.
Gene Name:
FABP3
Uniprot ID:
P05413
Uniprot Name:
Fatty acid-binding protein, heart
Molecular Weight:
14857.93 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Toxic substance binding
Specific Function:
Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.
Gene Name:
ALB
Uniprot ID:
P02768
Uniprot Name:
Serum albumin
Molecular Weight:
69365.94 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
  3. Spector AA, John K, Fletcher JE: Binding of long-chain fatty acids to bovine serum albumin. J Lipid Res. 1969 Jan;10(1):56-67. [PubMed:5773785 ]
Drug created on June 13, 2005 07:24 / Updated on August 02, 2017 16:49